Application US20190043619

METHODS AND APPARATUS FOR EVALUATING DEVELOPMENTAL CONDITIONS AND PROVIDING CONTROL OVER COVERAGE AND RELIABILITY
[+] Show Details

US20190043619

1. A computer-implemented method for determining a treatment for an individual for a neurological disorder, said method comprising: (10) (2)

(a) receiving data of said individual related to said neurological disorder; and

(b) evaluating said data using at least one classifier to select at least one therapeutic agent for treating said neurological disorder.

2. The method of claim 1, wherein said at least one therapeutic agent comprises a stimulant or antipsychotic drug for treating said neurological disorder. (0)

3. The method of claim 1, wherein said at least one therapeutic agent comprises amphetamine or an amphetamine-derived drug. (0)

4. The method of claim 1, wherein said at least one therapeutic agent is selected from the group consisting of risperidone, quetiapine, amphetamine, dextroamphetamine, methylphenidate, methamphetamine, dextroamphetamine, dexmethylphenidate, guanfacine, atomoxetine, lisdexamfetamine, clonidine, and aripiprazole, and modafinil. (0)

5. The method of claim 1, wherein said neurological disorder is selected from the group consisting of autism spectrum disorder, attention deficit disorder, attention deficit hyperactivity disorder, and dyslexia. (0)

6. The method of claim 1, wherein said data comprises active data generated from at least one active data source and passive data generated from at least one passive data source. (1) (0)

8. The method of claim 1, wherein said data comprises information acquired from at least one of genetic data, floral data, a sleep monitor, and eye tracking of said individual. (0)

9. The method of claim 1, wherein said data comprises at least one of demographic data and answers to a set of diagnostic questions. (0)

10. The method of claim 1, wherein said at least one classifier comprises an assessment model for providing an evaluation result based on said data, wherein said evaluation result is a first categorical determination or a first inconclusive determination with respect to a presence or absence of said neurological disorder. (2) (0)

11. The method of claim 10, wherein said first categorical determination for said presence or absence of said neurological disorder in said individual is based on a specified sensitivity and a specified specificity. (0)

12. The method of claim 10, wherein said at least one classifier comprises a subset of a plurality of tunable machine learning models. (2) (0)

13. The method of claim 12, further comprising: (0) (2)

14. The method of claim 12, further comprising: (0) (2)

15. The method of claim 1, wherein said at least one classifier comprises a chain of classifiers for providing an evaluation result for said neurological disorder based on said data. (1) (0)

17. The method of claim 1, wherein said at least one classifier comprises a therapeutic model for selecting said at least one therapeutic agent. (1) (0)

View Abstract and Specification Size

PDF with Images and Document Face >

Full Text Publication >

Application US20190043619

METHODS AND APPARATUS FOR EVALUATING DEVELOPMENTAL CONDITIONS AND PROVIDING CONTROL OVER COVERAGE AND RELIABILITY

Patent Matrix® Search